Fachliteratur Gastroenterologie: Neoplasien der Leber

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Leber » Neoplasie

30. April 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3797


	Artikel 1 - 20 / 75940

	Multifunctional double hairpin DNA polydopamine nano-system for "switch-on" detection and intervention of high-grade dysplastic nodules. Mikrochim Acta Zhou J, Feng J, Dong X, Zhang T, Wei Y, Wang Y, Shi C. PMID: 42053823 [PubMed - indexed for MEDLINE]
	Beyond silencing: integrative multi-omics and spatial profiling unravel the systems-level role of piRNAs in HBV-driven Hepatocarcinogenesis. Mol Biol Rep Zainb A, Altalbawy FMA, Younis SMD, Ali Al-Bazi SM, Eiada AA, Zain Al-Abdeen SH, Norberdiyeva M, Smerat A. PMID: 42053692 [PubMed - indexed for MEDLINE]
	Overcoming immune resistance in hepatocellular carcinoma: insights into mechanisms, predictive factors, and interventional strategies. Front Immunol Wang Z, Wu J, Li Q, Wen X. PMID: 42051530 [PubMed - indexed for MEDLINE]
	Durable response to FOLFOX plus serplulimab in AFP-producing gastric adenocarcinoma with liver metastases: a case report and literature review. Front Immunol Jin Y, Fu L, Zhao Y, Tong Z, Tan Y. PMID: 42051505 [PubMed - indexed for MEDLINE]
	New Pathological Insights into Biomarkers for Multimodal Therapeutic Approach in Hepatic Neuroendocrine Tumors: A Detailed Case Report. In Vivo Tsai YC, Lin CH, Hung CH, Ou JJ, Lee YT. PMID: 42049452 [PubMed - indexed for MEDLINE]
	Identification of Risk Factors for the Local Recurrence of Hepatocellular Carcinoma Post-radiofrequency Ablation. Anticancer Res Tanaka K, Kuwano A, Yada M, Suzuki H, Motomura K. PMID: 42049332 [PubMed - indexed for MEDLINE]
	AdvanTIG-206: a phase II, randomized study of ociperlimab plus tislelizumab and BAT1706 (bevacizumab biosimilar) versus tislelizumab and BAT1706 in first-line hepatocellular carcinoma. Cancer Immunol Immunother Ren Z, Huang Y, Guo Y, Hou MM, Wang W, Kuang M, Hao C, Wang W, Zhang Y, Song T, Dai C, Kuo HT, Bao Z, Zuo Y, Wang L, Zhu F, Fan J. PMID: 42047833 [PubMed - indexed for MEDLINE]
	CEUS-Based Microvascular Invasion Predictor in HCC: Improving Prognostic Stratification Following Thermal Ablation. Liver Int Chen K, Zhang S, Huang T, Xu Y, Zhang Q, Zhu Y, Wan P, Kong W, Wang W. PMID: 42047408 [PubMed - indexed for MEDLINE]
	Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Chinese Retrospective Multicenter Study Based on Global Meta-Analysis. Cancer Med Xu J, Zhang YL, Yang M, Deng Z, Li L, Wang T, Song J, Xu H, Wu J, Wu ZQ, Xu HG. PMID: 42047297 [PubMed - indexed for MEDLINE]
	CXCR4-Targeted Nanotherapeutics: A Promising Approach for Liver Fibrosis and Hepatocellular Carcinoma Management. Int J Nanomedicine Ullah A, Khan M, Zhang Y, Shafiq M, Ullah M, Abbas A, Ullah K, Xiangxiang X, Chen G, Diao Y. PMID: 42046739 [PubMed - indexed for MEDLINE]
	Enhancing immune response in advanced HCC with PVTT: rivaroxaban as a core adjuvant in combined therapy. J Immunother Cancer Yan Y, Zou D, Li Y, Ma H, Chen H. PMID: 42044974 [PubMed - indexed for MEDLINE]
	Asian Burden of Liver Cancer 1990-2021 and Predictions to 2040: An Analysis of the Global Burden of Disease Study 2021. Cancer Control Chen L, Zheng W, Ying H, Chen X, Yan H, Zhou B, Sun Y, Shao Q, Xu H, Jin B, Jin H, Fu B. PMID: 42044492 [PubMed - indexed for MEDLINE]
	Efficacy of Hepatic Artery Infusion Chemotherapy Combined With Regorafenib and Sintilimab Versus Regorafenib Alone in MSS/pMMR Colorectal Cancer Liver Metastases After Second-Line Treatment Failure. Cancer Med You R, Xu Q, Wang L, Leng B, Wang C, Yu Z, Lu Y, Diao L, Lu Y, Yin G. PMID: 42043896 [PubMed - indexed for MEDLINE]
	Intratumoral Proton Density Fat Fraction Predicts the Outcome of HAIC Combined With PD-1 Inhibitors in Advanced Hepatocellular Carcinoma. Cancer Med Ye Y, Li Y, Lu Y, Xu Y, Zhang L, Zhu Y, Li H, Li B, Zhou M, Yu D. PMID: 42043882 [PubMed - indexed for MEDLINE]
	Liver transplantation is the major determinant of â‰¥10-year survival in patients with hepatocellular carcinoma. Hepatol Commun Rezaee-Zavareh MS, Ahn JC, Kim H, Luu M, Ayoub W, Kuo A, Trivedi H, Wang Y, Vipani A, Todo T, Voidonikolas G, Steggerda JA, Wisel SA, Brennan TV, Ferrone C, Kim IK, Kosari K, Nissen N, Parikh ND, Singal AG, Yang JD. PMID: 42043868 [PubMed - indexed for MEDLINE]
	Combining External Beam Radiotherapy and Immunotherapy for the Treatment of Hepatocellular Carcinoma. Curr Oncol Le C, Abraham AG, Tankel K, Usmani N, Joseph K, Severin D, AlFaraj F, Dawson LA. PMID: 42041745 [PubMed - indexed for MEDLINE]
	Real-world efficacy and safety of transarterial chemoembolization plus sintilimab and bevacizumab biosimilar for intermediate-advanced hepatocellular carcinoma: a propensity score matching study. Front Immunol Deng LW, Liu JF, Yu HY, Peng B, Liu B, Feng SF, Liu DX, Sun YY, Chen Y, Chen JJ, Zhang C, Wang HQ, Xu GH, Liu L, Wei G, Ren Y, Cao L, Zhao Y, Yang XG. PMID: 42039163 [PubMed - indexed for MEDLINE]
	Cost-effectiveness analysis of atezolizumab and bevacizumab as first-line systemic therapy in unresectable hepatocellular carcinoma in Malaysia. J Med Econ Wong YF, Mohamed R, Sulaiman Shah AA, Chaiyakunapruk N, Patikorn C. PMID: 42033418 [PubMed - indexed for MEDLINE]
	An XGBoost-Based Multicenter Model for Predicting HBV-Related Hepatocellular Carcinoma: Development and Validation. Cancer Med Lin Y, Zhuo HY, Song HW, Zhou LN, Hong MZ, Lin C, Guo PF, Pan JS. PMID: 42033058 [PubMed - indexed for MEDLINE]
	Impact of Underlying Liver Disease on the Risk and Prognostic Factors of Breast Cancer Liver Metastases: A Retrospective Multicenter Cohort Study. Cancer Med Wang X, Zhang Y, Yang Q, Yang L, Wang Y, Zeng X, Zou L, Guo Y, Zhou W, Jiang Y, Wu J, Zhang P, Zhou S, Zheng G, Huang T, Wang G, Hu K. PMID: 42032971 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 75940

Seite 1 von 3797



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung